Here are the 8-K filings from Yubo Intl Biotech Ltd A (YBGJ) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow YBGJ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full YBGJ filings page.
Yubo International Biotech Limited reported a change in its independent auditor. On January 13, 2026, HHL LLP resigned as the company’s independent registered public accounting firm, and the board of directors accepted the resignation effective immediately. HHL’s audit report on the year ended December 31, 2024 contained no adverse or disclaimed opinion and was not qualified, other than an explanatory paragraph highlighting substantial doubt about the company’s ability to continue as a going concern.
For the fiscal years ended December 31, 2025 and December 31, 2024, and the interim period through January 13, 2026, the company states there were no disagreements with HHL on accounting principles, financial disclosures, or audit procedures, and no reportable events under SEC rules. The company engaged HCL, PLLC as its new independent registered public accountant on January 13, 2026 to audit the consolidated financial statements for the year ended December 31, 2025, and indicates it did not previously consult HCL on specific accounting issues or potential audit opinions.